Neoadjuvant chemotherapy is associated with a high rate of perioperative blood transfusion at the time of interval cytoreductive surgery

BACKGROUND: The oncologic safety of allogeneic blood transfusion in ovarian cancer patients is unknow. We sought to determine the prevalence and oncologic safety of perioperative allogeneic blood transfusion during interval cytoreduction surgery among women receiving neoadjuvant chemotherapy for ova...

Descripción completa

Detalles Bibliográficos
Autores principales: McCool, Kevin W, Sampene, Emmanuel, Polnaszek, Brock, Connor, Joseph, Medlin, Erin E, Barroilhet, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204018/
https://www.ncbi.nlm.nih.gov/pubmed/30367632
http://dx.doi.org/10.1186/s12885-018-4882-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204018/
https://www.ncbi.nlm.nih.gov/pubmed/30367632
http://dx.doi.org/10.1186/s12885-018-4882-8

Ejemplares similares